Event Speakers
John H. A. Amery: An Industry Perspective on the Use of Bioassays for Synthetic Peptide and Nucleotide Pharmaceuticals
Richard Dimarchi: The Emergence of Chemical Biotechnology and Its Application to Optimization of Endocrine Hormones
Richard Duke: Breceptin: Pre-Clinical Data and Clinical Development Plans for a Peptide-Based Bradykinin Antagonist in Small Cell Lung Cancer
Christian Elling: Development of Y2 and Y4 GI-Tract Satiety Signals as Anti-Obesity Agents
Angelika Fretzen: Linaclotide, a First-in-Class, Guanylate Cyclase C Agonist in Development for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation
Soumitra Ghosh: Integrated Neurohormonal Therapy for Obesity
Robert P. Hammer: Amino Acid Analogues in the Design of Functional Peptide Mimics
Gunnar Kaufmann: Bacterial Quorum Sensing as Target for Anti-Infective Therapy
Soren Kjareluff: NZ2114 Plectasin, a New Antibiotic for Treatment of Resistant Gram Positive Bacterial Infections
Claudio Mapelli: A Novel Class of 11-MER Peptide Agonists of the GLP-1 Receptor
Les Miranda: Identification of Potent, Selective, and Metabolically Stable Peptide Antagonists to the Calcitonin Gene-Related Peptide (CGRP) Receptor
Bruce Morimoto: Neuroprotection by AL-108: A Case Study for Development of a CNS-Active Peptide as a Treatment for AlzheimerÕs Disease
Ted Randolph: Conformational and Colloidal Contributions to Stability against Aggregation of Proteins
Chris Roberts: Development and Scale-up of an MC-4 Agonist
Rushia Turner: Using Click Chemistry to Synthesize and Study the Relative Permeabilities of Cyclic Peptides and Their Linear Precursors
Paul Wentworth: A Chemical Link Between Inflammation and Protein Misfolding Diseases
Presenting Sponsor
